MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells

Yicheng Xiong, Yao Wang, Lei Wang, Yan Huang, Yang Xu, Liancheng Xu, Yibing Guo, Jingjing Lu, Xiaohong Li, Mingyan Zhu, Haixin QianJournal of Cancer 2018 · DOI

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is characterized by high metastatic potential and resistance to therapy, largely driven by pancreatic cancer stem cells (PCSCs). This study identifies microRNA-30b (miR-30b) as a key regulator that is significantly downregulated in triple-positive (CD24<sup>+</sup>, CD44<sup>+</sup>, EpCAM<sup>+</sup>) PCSCs. We demonstrate that miR-30b directly targets the 3'UTR of Snail, a master regulator of the epithelial-mesenchymal transition (EMT). Overexpression of miR-30b suppresses EMT, reduces migratory and invasive capacities, and inhibits in vivo tumor growth. Clinical data reveal a negative correlation between miR-30b and Snail expression, with low miR-30b levels predicting poor prognosis in PDAC patients.

Introduction: The Challenge of Pancreatic Cancer Stem Cells

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, primarily due to late diagnosis and a high propensity for metastasis. At the heart of this malignancy are Pancreatic Cancer Stem Cells (PCSCs)—a small subpopulation of cells capable of self-renewal and driving tumor growth. These stem cells utilize a biological program called Epithelial-Mesenchymal Transition (EMT), where stationary "epithelial" cells transform into mobile "mesenchymal" cells, allowing them to spread throughout the body. While the transcription factor Snail is a known master regulator of this process, the specific mechanisms that keep Snail in check in pancreatic cancer have been poorly understood.

Methods and Validation

The researchers employed a multi-disciplinary approach to map the miR-30b/Snail axis:

  • Cell Sorting and Characterization: Fluorescence-Activated Cell Sorting (FACS) was used to isolate "triple-positive" PCSCs (marked by CD24+, CD44+, and EpCAM+) from the PANC-1 cell line.
FACS analysis of CD24 and CD44 expression in PANC-1 cells used to isolate the PCSC subpopulation.
  • Molecular Validation: To confirm the identity of the isolated PCSCs, the team measured the expression of stemness markers Oct4 and Nanog, which were significantly elevated compared to the parent cell line.
Expression levels of stemness markers Oct4 and Nanog are significantly elevated in isolated PCSCs at both mRNA (E) and protein (F, G) levels.
  • Targeting Assays: Luciferase reporter assays were used to prove that miR-30b directly binds to the Snail genetic sequence. Functional assays, including Transwell migration and in vivo mouse models, were used to measure the impact of miR-30b on cancer aggressiveness.
  • Clinical Correlation: Tissue microarrays from 100 PDAC patients were analyzed to compare miR-30b levels and Snail expression with actual patient survival outcomes.

Key Insights: miR-30b as a Tumor Suppressor

  • miR-30b is the "Missing Brake": While several members of the miR-30 family were downregulated in cancer stem cells, miR-30b showed the most significant decrease, marking it as a primary tumor suppressor.
  • Direct Targeting of Snail: The study confirms that miR-30b physically binds to the 3'UTR of Snail mRNA, preventing the protein from being synthesized and thus halting the EMT program.
  • Reversing the Phenotype: Overexpressing miR-30b was sufficient to flip the switch back, increasing the "glue" protein E-cadherin (epithelial marker) and decreasing N-cadherin (mesenchymal marker), effectively locking the cells in a less aggressive state.

Experimental and Clinical Results

  • Tumor Suppression: In mouse models, PCSCs overexpressing miR-30b formed significantly smaller and lighter tumors compared to control groups (P < 0.01).
  • Reduced Mobility: miR-30b mimics dramatically impaired the migratory and invasive capacities of PCSCs in lab assays (P < 0.001).
  • Clinical Significance: Low levels of miR-30b were strongly associated with neuro-invasion, advanced TNM stage, and poor tumor differentiation. Kaplan-Meier curves showed that high miR-30b expression is a significant predictor of longer patient survival (P = 0.0021).

Limitations and Future Directions

While the study provides a robust mechanism for how miR-30b regulates Snail, questions remain regarding the upstream factors that cause miR-30b downregulation in the first place. Additionally, the challenge of microRNA delivery to tumor sites in humans remains a significant hurdle for clinical translation. Future work should also validate these findings across a broader range of primary patient-derived cell lines to strengthen the clinical case for miR-30b-based therapies.

Summary updated

Abstract

Snail-mediated epithelial-mesenchymal transition (EMT) process plays a fundamental role in facilitating pancreatic ductal adenocarcinoma (PDAC) stemness and metastasis. In the present study, we revealed that microRNA-30 (miR-30) members, especially miR-30b, were remarkably downregulated in triple-positive (CD24<sup>+</sup>, CD44<sup>+</sup>, EpCAM<sup>+</sup>) pancreatic cancer stem cells (PCSCs). In addition, we revealed that miR-30b suppressed EMT process in PCSCs. Overexpression of miR-30b led to reduced expression of mesenchymal marker N-cadherin and the upregulation of epithelial marker E-cadherin. Moreover, both of TargetScan and PicTar algorithms predicted that miR-30b directly targeted Snail 3'UTR. Luciferase reporter assay showed that miR-30b could specifically reduce the translational activity of Snail wild-type 3'UTR, but not its mutant form. In line with these results, transwell assay demonstrated that overexpression of miR-30b mimic impaired migratory and invasive capacities of PCSCs. Furthermore, miR-30b overexpression suppresses in vivo tumorigenic potential of PDACs. Finally, a negative correlation between the expression of miR-30b and Snail was uncovered. Low level of miR-30b and high Snail expression both predict dismal prognosis in PDAC patients. Taken together, these findings implicate that miR-30b may suppress PCSC phenotype and PDAC metastasis through posttranscriptionally suppressing Snail expression, highlighting that miR-30b may serve as a therapeutic agent in the treatment of PDAC.
BibTeX
@article{xiong2018microrna,
  author = {Yicheng Xiong and Yao Wang and Lei Wang and Yan Huang and Yang Xu and Liancheng Xu and Yibing Guo and Jingjing Lu and Xiaohong Li and Mingyan Zhu and Haixin Qian},
  title = {{MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells}},
  journal = {Journal of Cancer},
  year = {2018},
  doi = {10.7150/jca.25006},
}
Figure